211 related articles for article (PubMed ID: 21506278)
1. Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Darji B; Siriki Y; Bandyopadhyay D; Joharapurkar A; Kshirsagar S; Patel H; Shaikh M; Sairam KV; Patel P
ChemMedChem; 2011 Jun; 6(6):1011-6. PubMed ID: 21506278
[No Abstract] [Full Text] [Related]
2. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Joharapurkar A; Dhanesha N; Shaikh M; Sairam KV; Kapadnis P
Bioorg Med Chem Lett; 2012 Jan; 22(2):1111-7. PubMed ID: 22189136
[TBL] [Abstract][Full Text] [Related]
3. (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Kim D; Wang L; Beconi M; Eiermann GJ; Fisher MH; He H; Hickey GJ; Kowalchick JE; Leiting B; Lyons K; Marsilio F; McCann ME; Patel RA; Petrov A; Scapin G; Patel SB; Roy RS; Wu JK; Wyvratt MJ; Zhang BB; Zhu L; Thornberry NA; Weber AE
J Med Chem; 2005 Jan; 48(1):141-51. PubMed ID: 15634008
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
[TBL] [Abstract][Full Text] [Related]
5. Rationalizing protein-ligand interactions for PTP1B inhibitors using computational methods.
Ajmani S; Karanam S; Kulkarni SA
Chem Biol Drug Des; 2009 Dec; 74(6):582-95. PubMed ID: 19824894
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.
Basu S; Prasad UV; Barawkar DA; De S; Palle VP; Menon S; Patel M; Thorat S; Singh UP; Das Sarma K; Waman Y; Niranjan S; Pathade V; Gaur A; Reddy S; Ansari S
Bioorg Med Chem Lett; 2012 Apr; 22(8):2843-9. PubMed ID: 22424978
[TBL] [Abstract][Full Text] [Related]
7. Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B.
Liu G; Szczepankiewicz BG; Pei Z; Janowick DA; Xin Z; Hajduk PJ; Abad-Zapatero C; Liang H; Hutchins CW; Fesik SW; Ballaron SJ; Stashko MA; Lubben T; Mika AK; Zinker BA; Trevillyan JM; Jirousek MR
J Med Chem; 2003 May; 46(11):2093-103. PubMed ID: 12747781
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors.
Gupta S; Pandey G; Rahuja N; Srivastava AK; Saxena AK
Bioorg Med Chem Lett; 2010 Oct; 20(19):5732-4. PubMed ID: 20797859
[TBL] [Abstract][Full Text] [Related]
9. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
[TBL] [Abstract][Full Text] [Related]
10. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice.
Jiang B; Guo S; Shi D; Guo C; Wang T
Eur J Med Chem; 2013 Jun; 64():129-36. PubMed ID: 23644196
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.
Combs AP
J Med Chem; 2010 Mar; 53(6):2333-44. PubMed ID: 20000419
[No Abstract] [Full Text] [Related]
13. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
Ramírez-Espinosa JJ; Rios MY; López-Martínez S; López-Vallejo F; Medina-Franco JL; Paoli P; Camici G; Navarrete-Vázquez G; Ortiz-Andrade R; Estrada-Soto S
Eur J Med Chem; 2011 Jun; 46(6):2243-51. PubMed ID: 21453996
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B.
Lin L; Shen Q; Chen GR; Xie J
Bioorg Med Chem; 2008 Nov; 16(22):9757-63. PubMed ID: 18922697
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.
Fukuda S; Ohta T; Sakata S; Morinaga H; Ito M; Nakagawa Y; Tanaka M; Matsushita M
Diabetes Obes Metab; 2010 Apr; 12(4):299-306. PubMed ID: 20380650
[TBL] [Abstract][Full Text] [Related]
16. [Sitagliptin. DPP-4 inhibitors as a useful extension of oral diabetes therapy?].
Matthes J; Faust M
Dtsch Med Wochenschr; 2008 Oct; 133(43):2233-7. PubMed ID: 18924057
[No Abstract] [Full Text] [Related]
17. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
18. Bis-aryl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
Aster SD; Graham DW; Kharbanda D; Patel G; Ponpipom M; Santorelli GM; Szymonifka MJ; Mundt SS; Shah K; Springer MS; Thieringer R; Hermanowski-Vosatka A; Wright SD; Xiao J; Zokian H; Balkovec JM
Bioorg Med Chem Lett; 2008 May; 18(9):2799-804. PubMed ID: 18434143
[TBL] [Abstract][Full Text] [Related]
19. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
20. 7-Phenyl-pyrido[2,3-d]pyrimidine-2,4-diamines: novel and highly selective protein tyrosine phosphatase 1B inhibitors.
Cheung AW; Banner B; Bose J; Kim K; Li S; Marcopulos N; Orzechowski L; Sergi JA; Thakkar KC; Wang BB; Yun W; Zwingelstein C; Berthel S; Olivier AR
Bioorg Med Chem Lett; 2012 Dec; 22(24):7518-22. PubMed ID: 23122867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
